Swiss Look to Expand Pediatric Trials
The Swiss Research Network of Clinical Pediatric Hubs (SwissPedNet) is seeking to promote clinical research in pediatrics in Switzerland.
Along with the Swiss Association of Paediatrics, SSP/SGP, SwissPedNet has issued a request for study proposals in pediatric health services research, and has set aside 120,000 Swiss Francs (around $121,000) to fund the initiative. Clinical research includes all investigations relating to patients seen either in private practices or clinics or both.
Switzerland’s five university children’s hospitals (Basel, Bern, Geneva, Lausanne and Zurich), as well as the three children’s hospitals of Aarau, Lucerne, and St. Gallen, set up SwissPedNet in 2012. Its task is to promote, facilitate, coordinate, and conduct clinical trials devoted to children, ranging from newborns to adolescents, in all pediatric disciplines. The ultimate goal is to enhance clinical research in paediatrics, both by supporting pediatric clinician scientists to foster their commitment to high-quality clinical research and by encouraging increased acceptance in the community of trials in children.
On November 20, 2015 the EOC Ticino’s department of pediatrics became the ninth clinical pediatric hub of SwissPedNet. In addition, the Swiss pediatric registry center at ISPM in Bern and SwissPedPha, the platform for pediatric pharmacology, are ordinary members of SwissPedNet.
SwissPedNet receives federal funding in the framework of the roadmap 2017-2020 (www.swisspednet.ch), and is closely linked to the Swiss Clinical Trial Organisation SCTO and its network of CTUs (www.scto.ch).
The submission deadline for new proposals is February 28, 2018. Click here for more details.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
